Integrated Three-Statement Model
Income statement · balance sheet · cash flow ·
quarterly FY2027–FY2029 · driver-based · synthetic company
Income statement
| $M | 2027Q1 | 2027Q2 | 2027Q3 | 2027Q4 | 2028Q1 | 2028Q2 | 2028Q3 | 2028Q4 | 2029Q1 | 2029Q2 | 2029Q3 | 2029Q4 |
|---|
| Revenue | 10.9 | 11.8 | 12.8 | 13.7 | 14.6 | 15.6 | 16.5 | 17.5 | 18.4 | 19.3 | 20.2 | 21.1 |
| Cost of revenue | -2.5 | -2.7 | -2.9 | -3.1 | -3.4 | -3.6 | -3.8 | -4.0 | -4.2 | -4.4 | -4.7 | -4.9 |
| Gross profit | 8.4 | 9.1 | 9.8 | 10.5 | 11.3 | 12.0 | 12.7 | 13.4 | 14.2 | 14.9 | 15.6 | 16.3 |
| | | | | | | | | | | | |
| Sales & marketing | -5.0 | -5.4 | -5.8 | -6.1 | -6.5 | -6.8 | -7.2 | -7.5 | -7.8 | -8.1 | -8.4 | -8.7 |
| Research & development | -3.3 | -3.6 | -3.8 | -4.1 | -4.4 | -4.7 | -5.0 | -5.2 | -5.5 | -5.8 | -6.1 | -6.3 |
| General & administrative | -1.5 | -1.6 | -1.7 | -1.8 | -2.0 | -2.1 | -2.2 | -2.4 | -2.5 | -2.6 | -2.7 | -2.9 |
| Depreciation | -0.4 | -0.4 | -0.5 | -0.5 | -0.5 | -0.5 | -0.6 | -0.6 | -0.7 | -0.7 | -0.7 | -0.8 |
| EBIT | -1.8 | -1.9 | -1.9 | -2.0 | -2.1 | -2.1 | -2.2 | -2.3 | -2.3 | -2.3 | -2.4 | -2.4 |
| Tax | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
| Net income | -1.8 | -1.9 | -1.9 | -2.0 | -2.1 | -2.1 | -2.2 | -2.3 | -2.3 | -2.3 | -2.4 | -2.4 |
| | | | | | | | | | | | |
| memo: SBC within opex | 1.4 | 1.5 | 1.6 | 1.7 | 1.8 | 1.9 | 2.0 | 2.1 | 2.2 | 2.3 | 2.4 | 2.5 |
| memo: billings | 11.0 | 12.3 | 13.6 | 14.7 | 15.9 | 16.9 | 18.0 | 19.0 | 19.9 | 20.9 | 21.8 | 22.7 |
Balance sheet
| $M | 2027Q1 | 2027Q2 | 2027Q3 | 2027Q4 | 2028Q1 | 2028Q2 | 2028Q3 | 2028Q4 | 2029Q1 | 2029Q2 | 2029Q3 | 2029Q4 |
|---|
| Cash | 57.5 | 57.0 | 57.0 | 57.4 | 57.9 | 58.7 | 59.6 | 60.7 | 61.9 | 63.2 | 64.5 | 66.0 |
| Accounts receivable | 7.0 | 7.8 | 8.6 | 9.4 | 10.1 | 10.8 | 11.4 | 12.1 | 12.7 | 13.3 | 13.9 | 14.4 |
| PP&E, net | 6.5 | 6.5 | 6.5 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.3 |
| Total assets | 70.9 | 71.3 | 72.1 | 73.2 | 74.5 | 75.9 | 77.5 | 79.2 | 81.0 | 82.8 | 84.8 | 86.8 |
| | | | | | | | | | | | |
| Accounts payable | 4.1 | 4.4 | 4.7 | 5.0 | 5.4 | 5.7 | 6.0 | 6.3 | 6.6 | 6.9 | 7.2 | 7.5 |
| Deferred revenue | 26.0 | 26.5 | 27.3 | 28.4 | 29.6 | 31.0 | 32.5 | 34.0 | 35.5 | 37.1 | 38.7 | 40.3 |
| Total liabilities | 30.1 | 30.9 | 32.0 | 33.4 | 35.0 | 36.7 | 38.5 | 40.3 | 42.2 | 44.1 | 46.0 | 47.8 |
| | | | | | | | | | | | |
| Paid-in capital | 90.6 | 92.0 | 93.6 | 95.3 | 97.1 | 99.0 | 101.0 | 103.1 | 105.3 | 107.7 | 110.1 | 112.6 |
| Retained earnings (deficit) | -49.8 | -51.6 | -53.6 | -55.6 | -57.7 | -59.8 | -62.0 | -64.2 | -66.5 | -68.9 | -71.3 | -73.7 |
| Total equity | 40.8 | 40.4 | 40.1 | 39.7 | 39.5 | 39.2 | 39.0 | 38.9 | 38.8 | 38.8 | 38.8 | 38.9 |
| | | | | | | | | | | | |
| Total liabilities + equity | 70.9 | 71.3 | 72.1 | 73.2 | 74.5 | 75.9 | 77.5 | 79.2 | 81.0 | 82.8 | 84.8 | 86.8 |
| check: A − (L + E) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 |
Cash flow statement (indirect)
| $M | 2027Q1 | 2027Q2 | 2027Q3 | 2027Q4 | 2028Q1 | 2028Q2 | 2028Q3 | 2028Q4 | 2029Q1 | 2029Q2 | 2029Q3 | 2029Q4 |
|---|
| Net income | -1.8 | -1.9 | -1.9 | -2.0 | -2.1 | -2.1 | -2.2 | -2.3 | -2.3 | -2.3 | -2.4 | -2.4 |
| + Depreciation | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 |
| + Stock-based compensation | 1.4 | 1.5 | 1.6 | 1.7 | 1.8 | 1.9 | 2.0 | 2.1 | 2.2 | 2.3 | 2.4 | 2.5 |
| − Increase in receivables | 2.8 | -0.9 | -0.8 | -0.7 | -0.7 | -0.7 | -0.7 | -0.6 | -0.6 | -0.6 | -0.6 | -0.6 |
| + Increase in payables | -0.0 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| + Increase in deferred revenue | 0.0 | 0.5 | 0.8 | 1.1 | 1.2 | 1.4 | 1.5 | 1.5 | 1.6 | 1.6 | 1.6 | 1.6 |
| Cash from operations | 2.8 | -0.0 | 0.4 | 0.8 | 1.1 | 1.3 | 1.5 | 1.7 | 1.8 | 2.0 | 2.1 | 2.2 |
| | | | | | | | | | | | |
| Capital expenditure | -0.4 | -0.4 | -0.4 | -0.5 | -0.5 | -0.5 | -0.6 | -0.6 | -0.6 | -0.7 | -0.7 | -0.7 |
| Cash from investing | -0.4 | -0.4 | -0.4 | -0.5 | -0.5 | -0.5 | -0.6 | -0.6 | -0.6 | -0.7 | -0.7 | -0.7 |
| Cash from financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| | | | | | | | | | | | |
| Net change in cash | 2.5 | -0.4 | -0.0 | 0.3 | 0.6 | 0.8 | 0.9 | 1.1 | 1.2 | 1.3 | 1.4 | 1.5 |
| Beginning cash | 55.0 | 57.5 | 57.0 | 57.0 | 57.4 | 57.9 | 58.7 | 59.6 | 60.7 | 61.9 | 63.2 | 64.5 |
| Ending cash | 57.5 | 57.0 | 57.0 | 57.4 | 57.9 | 58.7 | 59.6 | 60.7 | 61.9 | 63.2 | 64.5 | 66.0 |
| check: = balance-sheet cash | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Income statement
| $M | 2027Q1 | 2027Q2 | 2027Q3 | 2027Q4 | 2028Q1 | 2028Q2 | 2028Q3 | 2028Q4 | 2029Q1 | 2029Q2 | 2029Q3 | 2029Q4 |
|---|
| Revenue | 11.1 | 12.2 | 13.4 | 14.7 | 16.0 | 17.4 | 18.8 | 20.4 | 21.9 | 23.6 | 25.2 | 27.0 |
| Cost of revenue | -2.3 | -2.6 | -2.8 | -3.1 | -3.4 | -3.7 | -4.0 | -4.3 | -4.6 | -4.9 | -5.3 | -5.7 |
| Gross profit | 8.7 | 9.6 | 10.6 | 11.6 | 12.6 | 13.7 | 14.9 | 16.1 | 17.3 | 18.6 | 19.9 | 21.3 |
| | | | | | | | | | | | |
| Sales & marketing | -5.1 | -5.5 | -6.0 | -6.4 | -6.9 | -7.4 | -7.9 | -8.4 | -8.9 | -9.5 | -10.0 | -10.5 |
| Research & development | -3.3 | -3.7 | -4.0 | -4.4 | -4.8 | -5.2 | -5.7 | -6.1 | -6.6 | -7.1 | -7.6 | -8.1 |
| General & administrative | -1.5 | -1.6 | -1.8 | -2.0 | -2.2 | -2.3 | -2.5 | -2.7 | -3.0 | -3.2 | -3.4 | -3.6 |
| Depreciation | -0.4 | -0.4 | -0.5 | -0.5 | -0.5 | -0.6 | -0.6 | -0.6 | -0.7 | -0.7 | -0.8 | -0.8 |
| EBIT | -1.6 | -1.6 | -1.7 | -1.7 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 |
| Tax | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
| Net income | -1.6 | -1.6 | -1.7 | -1.7 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 |
| | | | | | | | | | | | |
| memo: SBC within opex | 1.4 | 1.5 | 1.7 | 1.8 | 1.9 | 2.1 | 2.3 | 2.4 | 2.6 | 2.8 | 2.9 | 3.1 |
| memo: billings | 11.5 | 13.1 | 14.8 | 16.4 | 18.0 | 19.7 | 21.3 | 23.0 | 24.8 | 26.5 | 28.3 | 30.2 |
Balance sheet
| $M | 2027Q1 | 2027Q2 | 2027Q3 | 2027Q4 | 2028Q1 | 2028Q2 | 2028Q3 | 2028Q4 | 2029Q1 | 2029Q2 | 2029Q3 | 2029Q4 |
|---|
| Cash | 57.7 | 57.9 | 58.6 | 59.8 | 61.4 | 63.3 | 65.6 | 68.2 | 71.0 | 74.2 | 77.7 | 81.5 |
| Accounts receivable | 7.3 | 8.4 | 9.4 | 10.4 | 11.5 | 12.5 | 13.6 | 14.6 | 15.7 | 16.9 | 18.0 | 19.2 |
| PP&E, net | 6.5 | 6.5 | 6.5 | 6.5 | 6.6 | 6.6 | 6.7 | 6.8 | 6.9 | 6.9 | 7.1 | 7.2 |
| Total assets | 71.5 | 72.7 | 74.5 | 76.7 | 79.4 | 82.4 | 85.8 | 89.5 | 93.6 | 98.0 | 102.8 | 107.9 |
| | | | | | | | | | | | |
| Accounts payable | 4.0 | 4.4 | 4.8 | 5.3 | 5.7 | 6.2 | 6.6 | 7.1 | 7.6 | 8.2 | 8.7 | 9.2 |
| Deferred revenue | 26.4 | 27.4 | 28.8 | 30.5 | 32.6 | 34.8 | 37.3 | 40.0 | 42.8 | 45.7 | 48.8 | 52.0 |
| Total liabilities | 30.5 | 31.8 | 33.6 | 35.8 | 38.2 | 41.0 | 43.9 | 47.1 | 50.4 | 53.9 | 57.5 | 61.2 |
| | | | | | | | | | | | |
| Paid-in capital | 90.6 | 92.1 | 93.8 | 95.5 | 97.5 | 99.6 | 101.8 | 104.3 | 106.9 | 109.6 | 112.5 | 115.7 |
| Retained earnings (deficit) | -49.6 | -51.2 | -52.9 | -54.6 | -56.4 | -58.2 | -60.0 | -61.8 | -63.6 | -65.5 | -67.3 | -69.0 |
| Total equity | 41.0 | 40.9 | 40.9 | 40.9 | 41.1 | 41.4 | 41.9 | 42.5 | 43.2 | 44.1 | 45.3 | 46.6 |
| | | | | | | | | | | | |
| Total liabilities + equity | 71.5 | 72.7 | 74.5 | 76.7 | 79.4 | 82.4 | 85.8 | 89.5 | 93.6 | 98.0 | 102.8 | 107.9 |
| check: A − (L + E) | 0.0 | -0.0 | 0.0 | -0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cash flow statement (indirect)
| $M | 2027Q1 | 2027Q2 | 2027Q3 | 2027Q4 | 2028Q1 | 2028Q2 | 2028Q3 | 2028Q4 | 2029Q1 | 2029Q2 | 2029Q3 | 2029Q4 |
|---|
| Net income | -1.6 | -1.6 | -1.7 | -1.7 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 | -1.8 |
| + Depreciation | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.8 | 0.8 |
| + Stock-based compensation | 1.4 | 1.5 | 1.7 | 1.8 | 1.9 | 2.1 | 2.3 | 2.4 | 2.6 | 2.8 | 2.9 | 3.1 |
| − Increase in receivables | 2.5 | -1.1 | -1.0 | -1.0 | -1.0 | -1.0 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 | -1.2 |
| + Increase in payables | -0.1 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| + Increase in deferred revenue | 0.4 | 1.0 | 1.4 | 1.7 | 2.0 | 2.3 | 2.5 | 2.7 | 2.8 | 3.0 | 3.1 | 3.2 |
| Cash from operations | 3.1 | 0.6 | 1.2 | 1.7 | 2.1 | 2.5 | 2.9 | 3.3 | 3.7 | 4.0 | 4.4 | 4.7 |
| | | | | | | | | | | | |
| Capital expenditure | -0.4 | -0.4 | -0.5 | -0.5 | -0.6 | -0.6 | -0.7 | -0.7 | -0.8 | -0.8 | -0.9 | -0.9 |
| Cash from investing | -0.4 | -0.4 | -0.5 | -0.5 | -0.6 | -0.6 | -0.7 | -0.7 | -0.8 | -0.8 | -0.9 | -0.9 |
| Cash from financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| | | | | | | | | | | | |
| Net change in cash | 2.7 | 0.2 | 0.7 | 1.2 | 1.6 | 1.9 | 2.3 | 2.6 | 2.9 | 3.2 | 3.5 | 3.8 |
| Beginning cash | 55.0 | 57.7 | 57.9 | 58.6 | 59.8 | 61.4 | 63.3 | 65.6 | 68.2 | 71.0 | 74.2 | 77.7 |
| Ending cash | 57.7 | 57.9 | 58.6 | 59.8 | 61.4 | 63.3 | 65.6 | 68.2 | 71.0 | 74.2 | 77.7 | 81.5 |
| check: = balance-sheet cash | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Income statement
| $M | 2027Q1 | 2027Q2 | 2027Q3 | 2027Q4 | 2028Q1 | 2028Q2 | 2028Q3 | 2028Q4 | 2029Q1 | 2029Q2 | 2029Q3 | 2029Q4 |
|---|
| Revenue | 10.8 | 11.4 | 11.9 | 12.4 | 12.9 | 13.3 | 13.7 | 14.1 | 14.4 | 14.8 | 15.1 | 15.3 |
| Cost of revenue | -2.7 | -2.8 | -3.0 | -3.1 | -3.2 | -3.3 | -3.4 | -3.5 | -3.6 | -3.7 | -3.8 | -3.8 |
| Gross profit | 8.1 | 8.5 | 8.9 | 9.3 | 9.6 | 10.0 | 10.3 | 10.6 | 10.8 | 11.1 | 11.3 | 11.5 |
| | | | | | | | | | | | |
| Sales & marketing | -5.4 | -5.6 | -5.8 | -6.0 | -6.2 | -6.3 | -6.5 | -6.6 | -6.7 | -6.7 | -6.8 | -6.9 |
| Research & development | -3.2 | -3.4 | -3.6 | -3.7 | -3.9 | -4.0 | -4.1 | -4.2 | -4.3 | -4.4 | -4.5 | -4.6 |
| General & administrative | -1.5 | -1.5 | -1.6 | -1.7 | -1.7 | -1.8 | -1.9 | -1.9 | -1.9 | -2.0 | -2.0 | -2.1 |
| Depreciation | -0.4 | -0.4 | -0.5 | -0.5 | -0.5 | -0.5 | -0.6 | -0.6 | -0.6 | -0.7 | -0.7 | -0.7 |
| EBIT | -2.4 | -2.5 | -2.5 | -2.6 | -2.6 | -2.7 | -2.7 | -2.7 | -2.7 | -2.8 | -2.8 | -2.8 |
| Tax | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
| Net income | -2.4 | -2.5 | -2.5 | -2.6 | -2.6 | -2.7 | -2.7 | -2.7 | -2.7 | -2.8 | -2.8 | -2.8 |
| | | | | | | | | | | | |
| memo: SBC within opex | 1.4 | 1.5 | 1.5 | 1.6 | 1.6 | 1.7 | 1.7 | 1.8 | 1.8 | 1.8 | 1.9 | 1.9 |
| memo: billings | 10.2 | 11.2 | 11.9 | 12.6 | 13.2 | 13.7 | 14.2 | 14.6 | 14.9 | 15.2 | 15.5 | 15.8 |
Balance sheet
| $M | 2027Q1 | 2027Q2 | 2027Q3 | 2027Q4 | 2028Q1 | 2028Q2 | 2028Q3 | 2028Q4 | 2029Q1 | 2029Q2 | 2029Q3 | 2029Q4 |
|---|
| Cash | 55.5 | 53.8 | 52.5 | 51.4 | 50.5 | 49.8 | 49.1 | 48.6 | 48.1 | 47.6 | 47.2 | 46.8 |
| Accounts receivable | 8.0 | 8.7 | 9.3 | 9.8 | 10.3 | 10.7 | 11.0 | 11.3 | 11.6 | 11.8 | 12.1 | 12.3 |
| PP&E, net | 6.5 | 6.4 | 6.4 | 6.4 | 6.3 | 6.2 | 6.1 | 6.0 | 5.9 | 5.8 | 5.6 | 5.4 |
| Total assets | 69.9 | 68.9 | 68.2 | 67.6 | 67.1 | 66.7 | 66.3 | 65.9 | 65.6 | 65.2 | 64.9 | 64.5 |
| | | | | | | | | | | | |
| Accounts payable | 4.2 | 4.4 | 4.6 | 4.8 | 5.0 | 5.1 | 5.3 | 5.4 | 5.5 | 5.6 | 5.7 | 5.8 |
| Deferred revenue | 25.5 | 25.3 | 25.3 | 25.5 | 25.9 | 26.3 | 26.7 | 27.2 | 27.7 | 28.1 | 28.6 | 29.0 |
| Total liabilities | 29.7 | 29.7 | 29.9 | 30.3 | 30.8 | 31.4 | 32.0 | 32.6 | 33.2 | 33.7 | 34.2 | 34.7 |
| | | | | | | | | | | | |
| Paid-in capital | 90.6 | 92.1 | 93.6 | 95.2 | 96.9 | 98.6 | 100.3 | 102.1 | 103.9 | 105.7 | 107.6 | 109.5 |
| Retained earnings (deficit) | -50.4 | -52.9 | -55.4 | -58.0 | -60.6 | -63.3 | -66.0 | -68.7 | -71.5 | -74.2 | -77.0 | -79.7 |
| Total equity | 40.2 | 39.2 | 38.2 | 37.2 | 36.2 | 35.3 | 34.3 | 33.4 | 32.4 | 31.5 | 30.6 | 29.8 |
| | | | | | | | | | | | |
| Total liabilities + equity | 69.9 | 68.9 | 68.2 | 67.6 | 67.1 | 66.7 | 66.3 | 65.9 | 65.6 | 65.2 | 64.9 | 64.5 |
| check: A − (L + E) | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
Cash flow statement (indirect)
| $M | 2027Q1 | 2027Q2 | 2027Q3 | 2027Q4 | 2028Q1 | 2028Q2 | 2028Q3 | 2028Q4 | 2029Q1 | 2029Q2 | 2029Q3 | 2029Q4 |
|---|
| Net income | -2.4 | -2.5 | -2.5 | -2.6 | -2.6 | -2.7 | -2.7 | -2.7 | -2.7 | -2.8 | -2.8 | -2.8 |
| + Depreciation | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 |
| + Stock-based compensation | 1.4 | 1.5 | 1.5 | 1.6 | 1.6 | 1.7 | 1.7 | 1.8 | 1.8 | 1.8 | 1.9 | 1.9 |
| − Increase in receivables | 1.8 | -0.7 | -0.6 | -0.5 | -0.5 | -0.4 | -0.4 | -0.3 | -0.3 | -0.2 | -0.2 | -0.2 |
| + Increase in payables | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| + Increase in deferred revenue | -0.5 | -0.2 | 0.1 | 0.2 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 |
| Cash from operations | 0.8 | -1.3 | -0.9 | -0.6 | -0.4 | -0.3 | -0.2 | -0.1 | 0.0 | 0.1 | 0.1 | 0.2 |
| | | | | | | | | | | | |
| Capital expenditure | -0.4 | -0.4 | -0.4 | -0.4 | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 |
| Cash from investing | -0.4 | -0.4 | -0.4 | -0.4 | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 | -0.5 |
| Cash from financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| | | | | | | | | | | | |
| Net change in cash | 0.5 | -1.7 | -1.3 | -1.1 | -0.9 | -0.7 | -0.6 | -0.6 | -0.5 | -0.5 | -0.4 | -0.4 |
| Beginning cash | 55.0 | 55.5 | 53.8 | 52.5 | 51.4 | 50.5 | 49.8 | 49.1 | 48.6 | 48.1 | 47.6 | 47.2 |
| Ending cash | 55.5 | 53.8 | 52.5 | 51.4 | 50.5 | 49.8 | 49.1 | 48.6 | 48.1 | 47.6 | 47.2 | 46.8 |
| check: = balance-sheet cash | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |